Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

 

 

 

WuXi PharmaTech (Cayman) Inc.

(Name of Issuer)

 

 

Ordinary Shares*

American Depositary Shares

(Title of Class of Securities)

 

 

929352102**

(CUSIP Number)

 

 

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

* Not for trading, but only in connection with the registration of American Depositary Shares each representing 8 ordinary shares.

 

** This CUSIP applies to the American Depositary Shares.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 929352102    SCHEDULE 13G    Page 2 of 8 Pages

 

  1  

NAMES OF REPORTING PERSONS/

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

            United Overseas Bank Limited

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Singapore

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

            63,604,4001

 

  6    SHARED VOTING POWER

 

            0

 

  7    SOLE DISPOSITIVE POWER

 

            63,604,4002

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            63,604,400

   
10  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            12.9%3

   
12  

TYPE OF REPORTING PERSON*

 

            CO

   

 

1

Includes (i) 34,453,450 ordinary shares held of record by UOB Hermes Asia Technology Fund (“UOB Hermes”); (ii) 17,015,350 ordinary shares held of record by UOB JAIC Venture Bio Investments Limited (“UOB JAIC”); and (iii) 12,135,600 ordinary shares held of record by UOB Venture Technology Investments Ltd. (“UOB Venture”). United Overseas Bank Limited is an investor in each of UOB Hermes and UOB JAIC through its subsidiary, UOB Capital Investments Pte Ltd and is a direct investor in UOB Venture. United Overseas Bank Limited is the ultimate controlling shareholder of each entity.

2

See footnote 1 above.

3

Based on 492,226,776 outstanding ordinary shares as of December 31, 2007.


CUSIP No. 929352102    SCHEDULE 13G    Page 3 of 8 Pages

 

  1  

NAMES OF REPORTING PERSONS/

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

            UOB Capital Investments Pte Ltd

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Singapore

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

            51,468,8004

 

  6    SHARED VOTING POWER

 

            0

 

  7    SOLE DISPOSITIVE POWER

 

            51,468,8005

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            51,468,800

   
10  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            10.5%6

   
12  

TYPE OF REPORTING PERSON*

 

            CO

   

 

4

Includes (i) 34,453,450 ordinary shares held of record by UOB Hermes; and (ii) 17,015,350 ordinary shares held of record by UOB JAIC. UOB Capital Investments Pte Ltd is the direct investor in both UOB Hermes and UOB JAIC, and is the wholly-owned subsidiary of United Overseas Bank Limited.

5

See footnote 4 above.

6

Based on 492,226,776 outstanding ordinary shares as of December 31, 2007.


CUSIP No. 929352102    SCHEDULE 13G    Page 4 of 8 Pages

 

  1  

NAMES OF REPORTING PERSONS/

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

            UOB Hermes Asia Technology Fund

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨

(b)  x

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Cayman Islands

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

            34,453,450

 

  6    SHARED VOTING POWER

 

            0

 

  7    SOLE DISPOSITIVE POWER

 

            34,453,450

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            34,453,450

   
10  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            7.0%7

   
12  

TYPE OF REPORTING PERSON*

 

            CO

   

 

7

Based on 492,226,776 outstanding ordinary shares as of December 31, 2007.


CUSIP No. 929352102    SCHEDULE 13G    Page 5 of 8 Pages

 

Item 1  

(a)

   Name of Issuer:      
     WuXi Pharmatech (Cayman) Inc. (“Issuer”)      
Item 1  

(b)

   Address of Issuer’s Principal Executive Offices:      
     288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s Republic of China      
Item 2  

(a)

   Name of Person Filing:      
     United Overseas Bank Limited      
     UOB Capital Investments Pte Ltd      
     UOB Hermes Asia Technology Fund      
Item 2  

(b)

   Address of Principal Business Office or, If None, Residence; Citizenship      
    

United Overseas Bank Limited

c/o UOB Venture Management Pte Ltd

80 Raffles Place #30-20

UOB Plaza 2

Singapore, 048624

     
    

UOB Capital Investments Pte Ltd

c/o UOB Venture Management Pte Ltd

80 Raffles Place #30-20

UOB Plaza 2

Singapore, 048624

     
    

UOB Hermes Asia Technology Fund

c/o UOB Venture Management Pte Ltd

80 Raffles Place #30-20

UOB Plaza 2

Singapore, 048624

     
Item 2  

(c)

   Citizenship      
     United Overseas Bank Limited - Singapore      
     UOB Capital Investments Pte Ltd - Singapore      
     UOB Hermes Asia Technology Fund - Cayman Islands      
Item 2   (d)    Title of Class of Securities:      
     Ordinary shares, par value US$0.02      
     American Depositary Shares      
Item 2   (e)    CUSIP Number:      
     929352102      
Item 3.   Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c):   
  Not applicable.   


CUSIP No. 929352102    SCHEDULE 13G    Page 6 of 8 Pages

 

Item 4.    Ownership      
   (a)    Amount Beneficially Owned:      

 

Reporting Person

   Amount
beneficially
owned:
   Percent
of class:
    Sole power
to vote or
direct

the vote:
   Shared
power to
vote or to
direct

the vote:
   Sole power to
dispose or to
direct the
disposition of:
   Shared power
to dispose or to
direct the
disposition of:

United Overseas Bank Limited

   63,604,400
ordinary
shares
   12.9 %   63,604,400
ordinary
shares
   0    63,604,400
ordinary
shares
   0

UOB Capital Investments Pte Ltd

   51,468,800

ordinary

shares

   10.5 %   51,468,800

ordinary

shares

   0    51,468,800

ordinary

shares

   0

UOB Hermes Asia Technology Fund

   34,453,450

ordinary
shares

   7.0 %   34,453,450

ordinary
shares

   0    34,453,450

ordinary
shares

   0
Item 5.    Ownership of Five Percent or Less of a Class   
   Not applicable.   
Item 6.    Ownership of More Than Five Percent on Behalf of Another Person      
   Not applicable.      
Item 7.    Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
   Not applicable.
Item 8.    Identification and Classification of Members of the Group      
   Not applicable.      
Item 9.    Notice of Dissolution of Group      
   Not applicable.      
Item 10.    Certifications      
   Not applicable.      


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. In addition, by signing below, the undersigned agrees that this Schedule 13G may be filed jointly on behalf of each of the Reporting Persons.

Dated: February 12, 2008

 

UNITED OVERSEAS BANK LIMITED
By:  

/s/ Wee Ee Cheong

Name:   Wee Ee Cheong
Title:   Director

 

UOB CAPITAL INVESTMENTS PTE LTD
By:  

/s/ Tay Tong Poh

Name:   Tay Tong Poh
Title:   Director

 

UOB HERMES ASIA TECHNOLOGY FUND
By:  

UOB Venture Management Pte Ltd,

its investment advisor

By:  

/s/ Seah Kian Wee

Name:   Seah Kian Wee
Title:   Managing Director


LIST OF EXHIBITS

 

Exhibit No.

 

Description

A   Joint Filing Agreement